Zentalis Pharmaceuticals (ZNTL) Goodwill & Intangibles (2019 - 2024)

Zentalis Pharmaceuticals' Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $3.7 million for Q3 2024.

• In Q3 2024, Goodwill & Intangibles changed 0.0% year-over-year to $3.7 million; the TTM figure through Sep 2024 stood at $3.7 million (changed 0.0% YoY), while the FY2023 annual figure was $3.7 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q3 2024 stood at $3.7 million, roughly flat from $3.7 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $12.5 million in Q1 2020, with the low at $3.7 million in Q3 2021.
• The 5-year median for Goodwill & Intangibles is $3.7 million (2021), against an average of $6.5 million.
• The sharpest annual moves came in 2020 and 2021: Goodwill & Intangibles changed 0.0% in 2020, then plunged 70.2% in 2021.
• Zentalis Pharmaceuticals' Goodwill & Intangibles stood at $12.5 million in 2020, then slumped by 70.2% to $3.7 million in 2021, then changed by 0.0% to $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then changed by 0.0% to $3.7 million in 2024.
• Business Quant data shows ZNTL's Goodwill & Intangibles at $3.7 million in Q3 2024, $3.7 million in Q2 2024, and $3.7 million in Q1 2024.